rethinkPeptides Search
Menu
Study breakdown

Beta-Endorphin Binds to Kidney Membranes Through Both Opioid and Non-Opioid Mechanisms

In VitroPreliminary evidence
The takeaway

Beta-endorphin binds to kidney membranes through two distinct sites — a high-affinity opioid receptor and a high-capacity non-opioid site — suggesting most kidney effects may bypass traditional opioid receptors.

Non-opioid binding dominates

The high-capacity non-opioid binding site on kidney membranes may mediate most of beta-endorphin's renal effects

What the researchers found

Beta-endorphin binds to kidney membranes through both opioid (high-affinity, low-capacity) and non-opioid (low-affinity, high-capacity) sites. The non-opioid binding involves the mid-portion of the peptide.

Why it matters

Beta-endorphin affects kidney function, and most of this may work through non-opioid mechanisms. This is important for understanding how opioid drugs affect kidney function.

How the study worked

Radioiodinated beta-endorphin binding to rat renal basolateral membranes was characterized by saturation isotherms, competition with naloxone and other opioid peptides, and Scatchard analysis.

What this study cannot tell us

In-vitro binding study. The functional consequences of non-opioid binding in the kidney were not tested. Only one species was examined.

How to read the evidence

Preliminary in-vitro binding study in rat kidneys. Characterizes binding sites but does not test functional consequences.

When this study was published

Published in 1990. Non-opioid effects of beta-endorphin remain an active research area.

The bigger picture

The kidney is critical for fluid balance and blood pressure. Finding that beta-endorphin affects kidneys mainly through non-opioid mechanisms means that opioid-blocking drugs may not prevent all of opioid peptides' kidney effects — important for understanding opioid drug side effects on kidney function.

Questions still open

  • What kidney functions are regulated by the non-opioid beta-endorphin binding site?
  • Are these non-opioid kidney effects clinically significant for patients on opioid therapy?

Common questions

What does non-opioid binding mean?
Beta-endorphin can stick to kidney cell membranes at sites that are not traditional opioid receptors. These sites recognize a different part of the peptide and are not blocked by opioid antagonists like naloxone.
Why does this matter for kidney function?
If most of beta-endorphin's kidney effects work through non-opioid sites, then opioid-blocking drugs won't prevent all kidney effects — important for managing patients on opioid therapy.

Read the original research

Specific binding of beta-endorphin to the isolated renal basolateral membranes in vitro.

Chemical & pharmaceutical bulletin, 38(12), 3395-9

Citation

Sato, H; Takeda, K; Terasaki, T; Tsuji, A. (1990). Specific binding of beta-endorphin to the isolated renal basolateral membranes in vitro.. Chemical & pharmaceutical bulletin, 38(12), 3395-9.